What Does the Future Hold for Biomarkers of Response to Extracorporeal Photopheresis for Mycosis Fungoides and Sézary Syndrome?

Extracorporeal photopheresis (ECP) is an FDA-approved immunotherapy for cutaneous T-cell lymphoma, which can provide a complete response in some patients. However, it is still being determined who will respond well, and predictive biomarkers are urgently needed to target patients for timely treatmen...

Descripción completa

Detalles Bibliográficos
Autor principal: Akilov, Oleg E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10527589/
https://www.ncbi.nlm.nih.gov/pubmed/37759543
http://dx.doi.org/10.3390/cells12182321

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10527589/
https://www.ncbi.nlm.nih.gov/pubmed/37759543
http://dx.doi.org/10.3390/cells12182321

Ejemplares similares